Medical News

RSS

Phase 1 study data of Keryx' perifosine for recurrent pediatric solid tumors presented at ASCO

Keryx Biopharmaceuticals, Inc. today announced that Phase 1 data of KRX-0401 (perifosine) in recurrent pediatric solid tumors was presented yesterday in the pediatric solid tumor poster discussion session held at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago, IL.

7 Jun 2010

Clivatuzumab tetraxetan shows promising results in patients with metastatic pancreatic cancer

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that its proprietary antibody, clivatuzumab tetraxetan, labeled with yttrium-90 plus low-dose gemcitabine continues to produce promising efficacy results in patients with previously untreated, inoperable, locally advanced or metastatic pancreatic cancer.

7 Jun 2010

Elsevier, InfoDesk partner to co-develop federated drug pipeline intelligence solution

Elsevier, a world-leading healthcare and scientific publisher, announced today that it has reached an agreement with Tarrytown, New York based InfoDesk to co-develop a federated drug pipeline intelligence solution for pharmaceutical and life science companies. The combination of Elsevier's business intelligence expertise and InfoDesk's technological know-how paves the way for the development of a powerful search and delivery tool that will increase productivity and improve the quality of results, securely inside or outside of a customer's firewall.

7 Jun 2010

Guardian Home Care Holdings, Cardiocom provide home telehealth technology to patients with chronic illnesses

Guardian Home Care Holdings, Inc., a leading provider of home care and hospice services, announced it has entered into a business relationship with Cardiocom to provide advanced home telehealth technology to patients with chronic illnesses. Cardiocom is a developer, manufacturer and clinical service provider of award-winning telehealth solutions.

7 Jun 2010

University Hospitals of Morecambe Bay NHS Trust implements Lorenzo Regional Care Release 1.9

CSC announced today that Lorenzo Regional Care Release 1.9 went live on June 1, 2010 at the University Hospitals of Morecambe Bay NHS Trust, with the implementation completed on June 3, 2010.

7 Jun 2010

CompuMed, CSHC partner to promote CardioGram and CardioGramKids ECG for school health centers

CompuMed, Inc., a telemedicine and medical informatics company, has partnered with the nonprofit California School Health Centers Association to promote CompuMed's CardioGram and CardioGramKids electrocardiogram telemedicine technologies for use in school health centers throughout California.

7 Jun 2010

MKMG implements CoActiv Medical's EXAM-VAULT QUAD-REDUNDANT ARCHIVING solution

Mount Kisco Medical Group (MKMG), the largest multi-specialty medical group in New York state, has selected CoActiv Medical's EXAM-VAULT® QUAD-REDUNDANT ARCHIVING® solution for the storage of its multi-modality imaging exams.

7 Jun 2010

Baylor Health Care System opens new Diabetes Health and Wellness Institute in South Dallas

Baylor Health Care System announced today the opening of a new Diabetes Health and Wellness Institute in an underserved community in South Dallas that it believes will ultimately influence the way diabetes is treated and prevented around the country.

7 Jun 2010

HP Enterprise Services signs seven-year agreement with NASCO

HP Enterprise Services today announced it has signed a seven-year agreement with Atlanta-based National Account Service Company LLC to enable the health insurance claims processor to expand its membership while lowering costs.

7 Jun 2010

The Female Health Company granted U.S. Patent for FC2 Female Condom

The Female Health Company today announced that on June 1, 2010, the U.S. Patent office issued patent number U.S. 7,726,316 B1 for its second generation product, the FC2 Female Condom. In addition to the newly issued U.S. patent, Spain, Greece and Turkey recently issued patents on the FC2 Female Condom.

7 Jun 2010

CytRx granted U.S. Patent for bafetinib

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the granting by the U.S. Patent and Trademark Office (USPTO) of U.S. Patent 7,728,131 for oncology drug candidate bafetinib, encompassing claims related to bafetinib's pharmaceutical compound and composition in all indications, as well as for use in methods for treating acute and chronic myelogenous leukemia and acute lymphoblastic leukemia.

7 Jun 2010

Inverness Medical Innovations extends 7.875% Senior Notes exchange offer

Inverness Medical Innovations, Inc. announced today that it has further extended its offer to exchange up to $100,000,000 in aggregate principal amount of 7.875% Senior Notes due 2016 that have been registered under the Securities Act of 1933, as amended, for a like principal amount of its outstanding unregistered 7.875% Senior Notes due 2016, to 5:00 p.m., New York City time, on Friday, June 11, 2010, unless further extended.

7 Jun 2010

OXiGENE reports positive final data from Phase 1 study of OXi4503 in patients with solid tumors

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that in collaboration with OXiGENE, Professor Gordon Rustin and colleagues from the Mount Vernon Cancer Research Centre, UK and other institutions in the United Kingdom, reported positive final data from an investigator-sponsored Phase 1 study of OXi4503 in patients with solid tumors.

7 Jun 2010

FDA approves 45mm GORE TAG Thoracic Endoprosthesis device

W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GORE® TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 - 42 mm and is now available for commercial use in the U.S.

7 Jun 2010

PTC receives $5.4M SDD Award to support development of drugs that target Bmi-1

PTC Therapeutics, Inc. today announced the receipt of a $5.4 million Seeding Drug Discovery Award from The Wellcome Trust to support the development of drugs that target Bmi-1, a protein that has been linked to drug resistant cancers.

7 Jun 2010

Harbor BioSciences to raise $2.06M through sale of common stock shares and warrants

Harbor BioSciences, Inc. announced today that it has entered into an agreement with certain institutional investors to raise approximately $2.06 million in gross proceeds through the sale of approximately 5.9 million shares of its common stock and warrants to purchase approximately 3.5 million shares of its common stock.

7 Jun 2010

SunTech Medical named Rookie Vendor of the Year

SunTech Medical was named 'Rookie Vendor of the Year' at Medline Industries, Inc.'s annual meeting for their HealthCare sales division in Montgomery, Texas. SunTech supplies Medline with the 247 Diagnostic Station, a blood pressure device that can also serve as a vital signs monitor, which Medline distributes to nursing homes and hospitals across the United States.

7 Jun 2010

BioSante's GVAX CML Vaccine granted FDA Orphan Drug designation

BioSante Pharmaceuticals, Inc. today announced the receipt of Orphan Drug designation for GVAX CML Vaccine in the treatment of chronic myeloid leukemia (CML) from the FDA's Office of Orphan Products Development. Orphan drug designation, as granted by the U.S. Orphan Drug Act, is for a product to treat a rare disease or condition that affects fewer than 200,000 people in the U.S. Orphan drug designation qualifies the sponsor of the product for tax credits and seven years of marketing exclusivity, among other benefits.

7 Jun 2010

Viking Systems to demonstrate 3DHD visualization system at The European Congress of Laparoscopy and Robotics

Viking Systems, Inc. announced today that its prototype Next Generation 3DHD Visualization System including Sony's 3DHD display will be demonstrated at The European Congress of Laparoscopy and Robotics allowing attendees an opportunity to participate in an interactive demonstration of the system. This event will be held in Rome, Italy from June 10 through June 12, 2010.

7 Jun 2010

Ranibizumab improves vision in patients with visual impairment due to DME: RESTORE study

Results from a new major diabetes eye health study may have the potential to change the way vision loss due to diabetic macular edema, a serious and devastating complication of diabetes, is treated. One year results from the RESTORE study show that 37 per cent of patients treated with ranibizumab only and 43 per cent of those treated with ranibizumab plus laser therapy, had a significant improvement in visual acuity of 10 letters or more on an eye chart, compared to 16 per cent of patients treated with laser alone - the current standard treatment for visual impairment due to DME.

7 Jun 2010

Medical News

Phase 1 study data of Keryx' perifosine for recurrent pediatric solid tumors presented at ASCO

Clivatuzumab tetraxetan shows promising results in patients with metastatic pancreatic cancer

Elsevier, InfoDesk partner to co-develop federated drug pipeline intelligence solution

Guardian Home Care Holdings, Cardiocom provide home telehealth technology to patients with chronic illnesses

University Hospitals of Morecambe Bay NHS Trust implements Lorenzo Regional Care Release 1.9

CompuMed, CSHC partner to promote CardioGram and CardioGramKids ECG for school health centers

MKMG implements CoActiv Medical's EXAM-VAULT QUAD-REDUNDANT ARCHIVING solution

Baylor Health Care System opens new Diabetes Health and Wellness Institute in South Dallas

HP Enterprise Services signs seven-year agreement with NASCO

The Female Health Company granted U.S. Patent for FC2 Female Condom

CytRx granted U.S. Patent for bafetinib

Inverness Medical Innovations extends 7.875% Senior Notes exchange offer

OXiGENE reports positive final data from Phase 1 study of OXi4503 in patients with solid tumors

FDA approves 45mm GORE TAG Thoracic Endoprosthesis device

PTC receives $5.4M SDD Award to support development of drugs that target Bmi-1

Harbor BioSciences to raise $2.06M through sale of common stock shares and warrants

SunTech Medical named Rookie Vendor of the Year

BioSante's GVAX CML Vaccine granted FDA Orphan Drug designation

Viking Systems to demonstrate 3DHD visualization system at The European Congress of Laparoscopy and Robotics

Ranibizumab improves vision in patients with visual impairment due to DME: RESTORE study

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News